Bank Of New York Mellon Corp Coherus Bio Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$5.89 - $10.52 $3.3 Million - $5.9 Million	560,900 New	560,900 $3.84 Billion
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $3.3 Million - $5.83 Million	579,408 New	579,408 $4.59 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $319,638 - $618,324	44,580 Added 7.7%	623,891 $6 Million
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $103,921 - $234,620	-17,734 Reduced 2.97%	579,311 $4.19 Million
Q1 2022 May 11, 2022	SELL	$10.92 - $16.41 $1.23 Million - $1.84 Million	-112,239 Reduced 15.82%	597,045 $7.71 Million
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $1.66 Million - $2 Million	-105,087 Reduced 12.9%	709,284 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$12.68 - $17.79 $295,088 - $414,008	23,272 Added 2.94%	814,371 $13.1 Million
Q2 2021 Aug 11, 2021	SELL	$12.95 - $15.41 $498,911 - $593,685	-38,526 Reduced 4.64%	791,099 $10.9 Million
Q1 2021 May 13, 2021	BUY	$14.42 - $21.39 $77,709 - $115,270	5,389 Added 0.65%	829,625 $12.1 Million
Q4 2020 Feb 09, 2021	BUY	$16.56 - $18.94 $1.89 Million - $2.16 Million	114,070 Added 16.06%	824,236 $14.3 Million
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $87,224 - $99,648	5,010 Added 0.71%	710,166 $13 Million
Q2 2020 Aug 12, 2020	BUY	$14.43 - $19.16 $6.18 Million - $8.2 Million	428,210 Added 154.62%	705,156 $12.6 Million
Q1 2020 May 06, 2020	SELL	$11.67 - $22.53 $16,629 - $32,105	-1,425 Reduced 0.51%	276,946 $4.49 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $91,970 - $120,355	5,632 Added 2.06%	278,371 $5.01 Million
Q3 2019 Nov 07, 2019	SELL	$16.3 - $23.37 $697,884 - $1 Million	-42,815 Reduced 13.57%	272,739 $5.53 Million
Q2 2019 Aug 12, 2019	BUY	$13.1 - $22.1 $1.19 Million - $2.01 Million	90,856 Added 40.43%	315,554 $6.97 Million
Q1 2019 May 14, 2019	BUY	$8.38 - $15.5 $18,067 - $33,418	2,156 Added 0.97%	224,698 $3.06 Million
Q4 2018 Feb 11, 2019	BUY	$8.65 - $16.28 $75,825 - $142,710	8,766 Added 4.1%	222,542 $2.01 Million
Q3 2018 Nov 09, 2018	BUY	$14.45 - $20.25 $397,216 - $556,652	27,489 Added 14.76%	213,776 $0
Q2 2018 Aug 06, 2018	BUY	$10.25 - $17.45 $95,314 - $162,267	9,299 Added 5.25%	186,287 $2.61 Million
Q1 2018 May 15, 2018	BUY	$9.1 - $13.7 $100,691 - $151,590	11,065 Added 6.67%	176,988 $1.96 Million
Q4 2017 Feb 09, 2018	BUY	$8.35 - $14.4 $1.39 Million - $2.39 Million	165,923	165,923 $1.46 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$17.8 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$16.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.77 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.49 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account